Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bf37c2caa97c4609118bebbe81f0e1f92> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bf37c2caa97c4609118bebbe81f0e1f92 NCIT_P378 "NCI" @default.
- Bf37c2caa97c4609118bebbe81f0e1f92 type Axiom @default.
- Bf37c2caa97c4609118bebbe81f0e1f92 annotatedProperty IAO_0000115 @default.
- Bf37c2caa97c4609118bebbe81f0e1f92 annotatedSource NCIT_C157039 @default.
- Bf37c2caa97c4609118bebbe81f0e1f92 annotatedTarget "An orally available, small-molecule, allosteric activator of the red cell isoform of pyruvate kinase (PK-R), with potential to improve hemolytic anemia in patients with pyruvate kinase deficiency (PKD). Upon oral administration, mitapivat binds to and activates PK-R, thereby enhancing glycolytic pathway activity, improving adenosine triphosphate (ATP) levels and reducing 2,3-diphosphoglycerate (2,3-DPG) levels. Mutations in PK-R cause deficiency in PK-R which prevents adequate red blood cell (RBC) glycolysis, leading to a buildup of the upstream glycolytic intermediate 2,3-DPG and deficiency in the PK-R product ATP." @default.